ResearcherFourth Affiliated Hospital of China Medical UniversityNo recent work listed

Yuxiang Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1173-8441; OpenAlex author ID A5100736984. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shuwei Chen · 1 shared paper, 2023 · strength 0.24
- Paper Resection of rectal metastasis after previous radical surgery for pancreatic cancer: Case report and literature review. DOI 10.1097/md.0000000000036365 ↗
Shaoyang Huang · 1 shared paper, 2023 · strength 0.24
- Paper Resection of rectal metastasis after previous radical surgery for pancreatic cancer: Case report and literature review. DOI 10.1097/md.0000000000036365 ↗
XU Chong-an · 1 shared paper, 2017 · strength 0.08
- Paper Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic … DOI 10.1007/s11523-017-0486-5 ↗
Qin Li · 1 shared paper, 2017 · strength 0.08
- Paper Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic … DOI 10.1007/s11523-017-0486-5 ↗
Xiuwei Zhang · 1 shared paper, 2017 · strength 0.08
- Paper Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic … DOI 10.1007/s11523-017-0486-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.